Home > Qtrly Results > DIVIS LABORATORIES

DIVIS LABORATORIES
Quarterly Results Analysis [Dec2025]

DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

DIVIS LABORATORIES Quarterly Results

Consolidated Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
Audited
Mar2024
UnAudited
Revenues ₹2,604 Cr ₹2,715 Cr ₹2,410 Cr ₹2,585 Cr ₹2,319 Cr ₹2,338 Cr ₹2,118 Cr ₹2,303 Cr
Expenses ₹1,714 Cr ₹1,827 Cr ₹1,681 Cr ₹1,699 Cr ₹1,576 Cr ₹1,622 Cr ₹1,496 Cr ₹1,572 Cr
Operating Income ₹890 Cr ₹888 Cr ₹729 Cr ₹886 Cr ₹743 Cr ₹716 Cr ₹622 Cr ₹731 Cr
Other Income ₹88 Cr ₹145 Cr ₹119 Cr ₹86 Cr ₹82 Cr ₹106 Cr ₹79 Cr ₹79 Cr
Interest ₹6 Cr ₹8 Cr ₹3 Cr ₹1 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹2 Cr
Depreciation ₹118 Cr ₹113 Cr ₹112 Cr ₹107 Cr ₹99 Cr ₹99 Cr ₹97 Cr ₹95 Cr
Profit Before Tax ₹780 Cr ₹912 Cr ₹733 Cr ₹864 Cr ₹726 Cr ₹722 Cr ₹604 Cr ₹713 Cr
Profit After Tax ₹583 Cr ₹689 Cr ₹545 Cr ₹662 Cr ₹589 Cr ₹510 Cr ₹430 Cr ₹538 Cr
EPS ₹22.00 ₹26.00 ₹20.57 ₹24.98 ₹22.23 ₹19.25 ₹16.23 ₹20.30
Industry Peers & Returns1W1M1Y
DIVIS LABORATORIES 5.5% -0.2% 0.8%
SUN PHARMACEUTICAL INDUSTRIES 0.5% -1.5% -2.6%
CIPLA 1.3% -7.9% -6.6%
TORRENT PHARMACEUTICALS 2.1% 2.8% 30.9%
DR REDDYS LABORATORIES 2% 4.5% 2.3%
MANKIND PHARMA 0.2% -6.3% -16.6%
ZYDUS LIFESCIENCES -0.8% 0.3% -9.3%
LUPIN -0.4% 0.9% 0.8%
AUROBINDO PHARMA -3.1% -2.3% -5.8%

DIVIS LABORATORIES Quarterly Revenues

Revenues
Q-o-Q

-4.09 %

Y-o-Y

12.29 %

Quarters Revenues % Change
Dec2025 ₹2,604 Cr
-4.09
Sep2025 ₹2,715 Cr
12.66
Jun2025 ₹2,410 Cr
-6.77
Mar2025 ₹2,585 Cr
11.47
Dec2024 ₹2,319 Cr
-0.81
Sep2024 ₹2,338 Cr
10.39
Jun2024 ₹2,118 Cr
-8.03
Mar2024 ₹2,303 Cr -

DIVIS LABORATORIES Quarterly Operating Profit

Operating Profit
Q-o-Q

0.23 %

Y-o-Y

19.78 %

Quarters Operating Profit % Change
Dec2025 ₹890 Cr
0.23
Sep2025 ₹888 Cr
21.81
Jun2025 ₹729 Cr
-17.72
Mar2025 ₹886 Cr
19.25
Dec2024 ₹743 Cr
3.77
Sep2024 ₹716 Cr
15.11
Jun2024 ₹622 Cr
-14.91
Mar2024 ₹731 Cr -
Operating Margins
Q-o-Q

4.49 %

Y-o-Y

6.68 %

Quarters Operating Margin% % Change
Dec2025 34.18%
4.49
Sep2025 32.71%
8.13
Jun2025 30.25%
-11.73
Mar2025 34.27%
6.96
Dec2024 32.04%
4.64
Sep2024 30.62%
4.26
Jun2024 29.37%
-7.47
Mar2024 31.74% -

DIVIS LABORATORIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-15.38 %

Y-o-Y

-1.02 %

Quarters Profit After Tax % Change
Dec2025 ₹583 Cr
-15.38
Sep2025 ₹689 Cr
26.42
Jun2025 ₹545 Cr
-17.67
Mar2025 ₹662 Cr
12.39
Dec2024 ₹589 Cr
15.49
Sep2024 ₹510 Cr
18.60
Jun2024 ₹430 Cr
-20.07
Mar2024 ₹538 Cr -
PAT Margins
Q-o-Q

-11.78 %

Y-o-Y

-11.85 %

Quarters PAT Margin(%) % Change
Dec2025 22.39 %
-11.78
Sep2025 25.38 %
12.25
Jun2025 22.61 %
-11.71
Mar2025 25.61 %
0.83
Dec2024 25.4 %
16.46
Sep2024 21.81 %
7.44
Jun2024 20.3 %
-13.10
Mar2024 23.36 % -

DIVIS LABORATORIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-15.38 %

Y-o-Y

-1.03 %

Quarters EPS % Change
Dec2025 ₹22
-15.38
Sep2025 ₹26
26.40
Jun2025 ₹20.57
-17.65
Mar2025 ₹24.98
12.37
Dec2024 ₹22.23
15.48
Sep2024 ₹19.25
18.61
Jun2024 ₹16.23
-20.05
Mar2024 ₹20.3 -

You may also like the below Video Courses